Gornalusse, G.G.; Vojtech, L.N.; Levy, C.N.; Hughes, S.M.; Kim, Y.; Valdez, R.; Pandey, U.; Ochsenbauer, C.; Astronomo, R.; McElrath, J.;
et al. Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency. Viruses 2021, 13, 1472.
https://doi.org/10.3390/v13081472
AMA Style
Gornalusse GG, Vojtech LN, Levy CN, Hughes SM, Kim Y, Valdez R, Pandey U, Ochsenbauer C, Astronomo R, McElrath J,
et al. Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency. Viruses. 2021; 13(8):1472.
https://doi.org/10.3390/v13081472
Chicago/Turabian Style
Gornalusse, Germán Gustavo, Lucia N. Vojtech, Claire N. Levy, Sean M. Hughes, Yeseul Kim, Rogelio Valdez, Urvashi Pandey, Christina Ochsenbauer, Rena Astronomo, Julie McElrath,
and et al. 2021. "Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency" Viruses 13, no. 8: 1472.
https://doi.org/10.3390/v13081472
APA Style
Gornalusse, G. G., Vojtech, L. N., Levy, C. N., Hughes, S. M., Kim, Y., Valdez, R., Pandey, U., Ochsenbauer, C., Astronomo, R., McElrath, J., & Hladik, F.
(2021). Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency. Viruses, 13(8), 1472.
https://doi.org/10.3390/v13081472